Koch Kevin

Edgewise Therapeutics, Inc. · President and CEO

Koch Kevin is listed in public filings as director, officer: President and CEO. This Koch Kevin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Edgewise Therapeutics, Inc. (EWTX). Investors use Koch Kevin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Edgewise Therapeutics, Inc.EWTX$107k8k sharesSellAug 12, 2025$13.39--